Cancer, Data and the Fallacy of the $1000 Genome


June 21, 2012 | In his first "Hacking Healthcare" blog, occasional Bio-IT World contributor Jim Golden discusses the central theme of a recent talk by Brigham & Women's Hospital pathologist Mark Boguski: "The time of the $1000 genome meme is over.  It served us well for years –  driving advances in instrumentation, chemistry and biology.  But now it is reducing clinical credibility.  It’s time for it to leave the lexicon of healthcare; it has to go." Forbes.com
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1





For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.